{"id":11253,"date":"2026-11-15T20:27:18","date_gmt":"2026-11-16T01:27:18","guid":{"rendered":"https:\/\/www.inflation.us\/news\/?p=11253"},"modified":"2026-11-15T20:27:21","modified_gmt":"2026-11-16T01:27:21","slug":"invest-in-stocks-that-have-a-100-percent-chance-of-going-up","status":"publish","type":"post","link":"https:\/\/www.inflation.us\/news\/articles\/invest-in-stocks-that-have-a-100-percent-chance-of-going-up\/","title":{"rendered":"Invest in Stocks That Have a 100% Chance of Going Up"},"content":{"rendered":"\n<div style=\"width:100%; max-width:650px; margin:0 auto; padding:0 10px; box-sizing:border-box; font-family:Arial,Helvetica,sans-serif; font-size:14px; line-height:1.65; color:#333333; -webkit-text-size-adjust:100%; -ms-text-size-adjust:100%; text-size-adjust:100%;\">\n\n  <p style=\"margin:0 0 18px; padding:0;\">\n    In NIA&#8217;s opinion, it is a good idea to\n    <span style=\"color:#2980b9;\"><strong>focus<\/strong><\/span>\n    on <span style=\"color:#27ae60;\"><strong>investing<\/strong><\/span>\n    into stocks with a\n    <span style=\"color:#27ae60;\"><strong>100% chance of going up<\/strong><\/span>\n    in 2027, and the #1 greatest example of this in today&#8217;s market is\n    <strong>Medicure (TSXV: MPH)<\/strong>.\n    Besides <strong>Celtic plc (LSE: CCP)<\/strong>, it is the only stock that\n    <strong>NIA&#8217;s President<\/strong> is in the process of\n    <span style=\"color:#27ae60;\"><strong>accumulating<\/strong><\/span>\n    right now.\n  <\/p>\n\n  <p style=\"margin:0 0 18px; padding:0;\">\n    <strong>MPH&#8217;s current market cap<\/strong> at\n    <strong>$3.70 per share<\/strong> is only\n    <span style=\"color:#27ae60;\"><strong>US$27.07 million<\/strong><\/span>.\n  <\/p>\n\n  <p style=\"margin:0 0 18px; padding:0;\">\n    <strong>MPH<\/strong> previously spent\n    <strong>US$19 million\n    <span style=\"color:#27ae60;\">acquiring<\/span>\n    AGGRASTAT&reg;<\/strong>, a drug that continues to generate significant revenue,\n    <strong>US$7 million\n    <span style=\"color:#27ae60;\">acquiring<\/span>\n    ZYPITAMAG&reg;<\/strong>, a drug with\n    <strong><span style=\"color:#27ae60;\">rapid revenue growth<\/span><\/strong>,\n    and <strong>US$9 million\n    <span style=\"color:#27ae60;\">acquiring<\/span>\n    three pharmacies<\/strong> located in North Carolina, Oregon, and Washington State.\n    <strong>MPH<\/strong> spent\n    <strong>US$35 million\n    <span style=\"color:#27ae60;\">acquiring<\/span><\/strong>\n    these <strong>revenue-generating\n    <span style=\"color:#27ae60;\">assets<\/span><\/strong>,\n    yet its <strong>market cap<\/strong> is only\n    <strong>US$27.07 million<\/strong>, which means\n    <strong>MPH<\/strong> is receiving\n    <span style=\"color:#e74c3c;\"><strong>$0<\/strong><\/span>\n    <strong>in value<\/strong> for <strong>MC-1<\/strong>,\n    a drug that is currently in <strong>Phase 3 trials<\/strong>\n    and NIA believes has a\n    <span style=\"color:#27ae60;\"><strong>100% chance<\/strong><\/span>\n    of <span style=\"color:#2980b9;\"><strong>approval<\/strong><\/span>.\n  <\/p>\n\n  <p style=\"margin:0 0 18px; padding:0;\">\n    <strong>MPH<\/strong> spent a total of\n    <span style=\"color:#27ae60;\"><strong>US$120 million+<\/strong><\/span>\n    on <strong>MC-1 R&amp;D<\/strong> since 1997,\n    yet is <span style=\"color:#27ae60;\"><strong>receiving<\/strong><\/span>\n    <strong><span style=\"color:#e74c3c;\">less than zero<\/span> value<\/strong>\n    for it when its current <strong>Phase 3 trial<\/strong>\n    is going smoothly, and after\n    <strong>FDA <span style=\"color:#2980b9;\">approval<\/span><\/strong>,\n    the company will\n    <span style=\"color:#27ae60;\"><strong>receive<\/strong><\/span>\n    an <strong>FDA Priority Review Voucher (PRV)<\/strong>\n    that it will sell to a\n    <strong><span style=\"color:#2980b9;\">major<\/span>\n    pharmaceutical company<\/strong>.\n    Less than one week ago, <strong>Scholar Rock<\/strong>\n    entered into an agreement to sell a <strong>PRV<\/strong>\n    for <span style=\"color:#27ae60;\"><strong>US$205 million<\/strong><\/span>.\n    This means <strong>MPH<\/strong> over the next 6-12 months will\n    <span style=\"color:#27ae60;\"><strong>rise<\/strong><\/span>\n    from a <strong>market cap<\/strong> of\n    <strong>US$27.07 million<\/strong> today\n    <span style=\"color:#27ae60;\"><strong>up to<\/strong><\/span>\n    a <strong>market cap<\/strong> of\n    <span style=\"color:#27ae60;\"><strong>over US$205 million<\/strong><\/span>\n    and has\n    <span style=\"color:#e74c3c;\"><strong>little\/no downside risk<\/strong><\/span>.\n  <\/p>\n\n  <p style=\"margin:0 0 18px; padding:0;\">\n    Be sure to tell every family member and friend you know to\n    <strong><span style=\"color:#2980b9;\">research<\/span> MPH<\/strong>\n    during the <strong>Thanksgiving and Christmas Holidays<\/strong>.\n    It will become the\n    <span style=\"color:#27ae60;\"><strong>#1 largest percentage gainer of 2027<\/strong><\/span>.\n    We are <span style=\"color:#2980b9;\"><strong>1,000% sure<\/strong><\/span>\n    of it.\n  <\/p>\n\n  <p style=\"margin:16px 0 0; padding:0; font-family:Arial,Helvetica,sans-serif; font-size:11px; line-height:1.5; color:#777777; font-style:italic;\">\n    Past performance is not indicative of future results.\n    NIA is not an investment advisor and does not provide investment advice.\n    Always do your own research and make your own investment decisions.\n    NIA&#8217;s President has purchased 87,000 shares of MPH and intends to buy more shares.\n    NIA&#8217;s President has purchased 78,000 shares of CCP and intends to buy more shares.\n    This communication is for informational and educational purposes only.\n  <\/p>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In NIA&#8217;s opinion, it is a good idea to focus on investing into stocks with a 100% chance of going up in 2027, and the #1 greatest example of this in today&#8217;s market is Medicure (TSXV: MPH). Besides Celtic plc (LSE: CCP), it is the only stock that NIA&#8217;s President is in the process of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[365,30,414,46],"class_list":["post-11253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-biotech","tag-ccp","tag-mph","tag-sports"],"_links":{"self":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/comments?post=11253"}],"version-history":[{"count":1,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11253\/revisions"}],"predecessor-version":[{"id":11255,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11253\/revisions\/11255"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media\/11254"}],"wp:attachment":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media?parent=11253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/categories?post=11253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/tags?post=11253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}